A compartmentalized microfluidic neuromuscular co-culture system reveals spatial aspects of GDNF functions

Journal of Cell Science

Volumn 128, Issue 6, 2015, Pages 1241-1252

  Zahavi, Eitan Erez ^a   Ionescu, Ariel ^a   Gluska, Shani ^a   Gradus, Tal ^a   Ben Yaakov, Keren ^a   Perlson, Eran ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Axon degeneration; Axonal transport; GDNF; Microfluidic chamber; Neuromuscular junction; Neurotrophic factors

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; CALCIUM; PROTEIN KINASE B;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL BODY; CELL COMPARTMENTALIZATION; COCULTURE; CONTROLLED STUDY; EMBRYO; MICROFLUIDICS; MOTONEURON; MOTOR NERVE; MOUSE; MUSCLE CELL; MUSCLE INNERVATION; NERVE CELL DEGENERATION; NERVE CELL DIFFERENTIATION; NERVE CELL GROWTH; NERVE ENDING; NERVE FIBER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RETROGRADE DEGENERATION; ANIMAL; AXON; CELL CULTURE; CYTOLOGY; ENZYME IMMUNOASSAY; FLUORESCENCE MICROSCOPY; METABOLISM; NEUROMUSCULAR JUNCTION; PHOSPHORYLATION; PHYSIOLOGY; SKELETAL MUSCLE; SPINAL CORD;

ANIMALS; AXONS; CALCIUM; CELLS, CULTURED; COCULTURE TECHNIQUES; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; IMMUNOENZYME TECHNIQUES; MICROFLUIDICS; MICROSCOPY, FLUORESCENCE; MOTOR NEURONS; MUSCLE, SKELETAL; NEUROMUSCULAR JUNCTION; OXIDATIVE STRESS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SPINAL CORD;

EID: 84925434739     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.167544     Document Type: Article

References (47)

1. Acsadi, G., Anguelov, R. A., Yang, H., Toth, G., Thomas, R., Jani, A., Wang, Y., Ianakova, E., Mohammad, S., Lewis, R. A. et al. (2002). Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy. Hum. Gene Ther. 13, 1047-1059.
2. Airaksinen, M. S. and Saarma, M. (2002). The GDNF family: signalling, biological functions and therapeutic value. Nat. Rev. Neurosci. 3, 383-394.
3. Baudet, C., Pozas, E., Adameyko, I., Andersson, E., Ericson, J. and Ernfors, P. (2008). Retrograde signaling onto Ret during motor nerve terminal maturation. J. Neurosci. 28, 963-975.
4. Beauchamp, J. R., Heslop, L., Yu, D. S., Tajbakhsh, S., Kelly, R. G., Wernig, A., Buckingham, M. E., Partridge, T. A. and Zammit, P. S. (2000). Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J. Cell Biol. 151, 1221-1234.
5. Conforti, L., Adalbert, R. and Coleman, M. P. (2007). Neuronal death: where does the end begin? Trends Neurosci. 30, 159-166.
6. Coulpier, M. and Ibáñez, C. F. (2004). Retrograde propagation of GDNFmediated signals in sympathetic neurons. Mol. Cell. Neurosci. 27, 132- 139.
7. Dadon-Nachum, M., Melamed, E. and Offen, D. (2011). The ''dying-back'' phenomenon of motor neurons in ALS. J. Mol. Neurosci. 43, 470-477.
8. Daniels, M. P., Lowe, B. T., Shah, S., Ma, J., Samuelsson, S. J., Lugo, B., Parakh, T. and Uhm, C. S. (2000). Rodent nerve-muscle cell culture system for studies of neuromuscular junction development: refinements and applications. Microsc. Res. Tech. 49, 26-37.
9. Dutton, E. K., Uhm, C. S., Samuelsson, S. J., Schaffner, A. E., Fitzgerald, S. C. and Daniels, M. P. (1995). Acetylcholine receptor aggregation at nerve-muscle contacts in mammalian cultures: induction by ventral spinal cord neurons is specific to axons. J. Neurosci. 15, 7401-7416.
10. Eleftheriadou, I., Trabalza, A., Ellison, S., Gharun, K. and Mazarakis, N. (2014). Specific retrograde transduction of spinal motor neurons using lentiviral vectors targeted to presynaptic NMJ receptors. Mol. Ther. 22, 1285-1298.
11. Fischer, L. R., Culver, D. G., Tennant, P., Davis, A. A., Wang, M., Castellano- Sanchez, A., Khan, J., Polak, M. A. and Glass, J. D. (2004). Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185, 232-240.
12. Giller, E. L., Jr, Schrier, B. K., Shainberg, A., Fisk, H. R. and Nelson, P. G. (1973). Choline acetyltransferase activity is increased in combined cultures of spinal cord and muscle cells from mice. Science 182, 588-589.
13. Gluska, S., Zahavi, E. E., Chein, M., Gradus, T., Bauer, A., Finke, S. and Perlson, E. (2014). Rabies virus hijacks and accelerates the p75NTR retrograde axonal transport machinery. PLoS Pathog. 10, e1004348.
14. Gould, T. W., Buss, R. R., Vinsant, S., Prevette, D., Sun, W., Knudson, C. M., Milligan, C. E. and Oppenheim, R. W. (2006). Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J. Neurosci. 26, 8774-8786.
15. Harrington, A. W. and Ginty, D. D. (2013). Long-distance retrograde neurotrophic factor signalling in neurons. Nat. Rev. Neurosci. 14, 177-187.
16. Henderson, C. E. and Bloch-Gallego, E. C. W. (1995). Purified Embryonic Motoneurons (ed. J. W. G. Cohen). London: Oxford University Press.
17. Henderson, C. E., Phillips, H. S., Pollock, R. A., Davies, A. M., Lemeulle, C., Armanini, M., Simmons, L., Moffet, B., Vandlen, R. A., Simpson LC corrected to Simmons, L. et al. (1994). GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266, 1062- 1064.
18. Houenou, L. J., Oppenheim, R. W., Li, L., Lo, A. C. and Prevette, D. (1996). Regulation of spinal motoneuron survival by GDNF during development and following injury. Cell Tissue Res. 286, 219-223.
19. Ibáñez, C. F. (2007). Message in a bottle: long-range retrograde signaling in the nervous system. Trends Cell Biol. 17, 519-528.
20. Kanning, K. C., Kaplan, A. and Henderson, C. E. (2010). Motor neuron diversity in development and disease. Annu. Rev. Neurosci. 33, 409-440.
21. Keller-Peck, C. R., Feng, G., Sanes, J. R., Yan, Q., Lichtman, J. W. and Snider, W. D. (2001). Glial cell line-derived neurotrophic factor administration in postnatal life results in motor unit enlargement and continuous synaptic remodeling at the neuromuscular junction. J. Neurosci. 21, 6136-6146.
22. Kole, A. J., Annis, R. P. and Deshmukh, M. (2013). Mature neurons: equipped for survival. Cell Death Dis. 4, e689.
23. Krakora, D., Macrander, C. and Suzuki, M. (2012). Neuromuscular junction protection for the potential treatment of amyotrophic lateral sclerosis. Neurol. Res. Int. 2012, 379657.
24. Krakora, D., Mulcrone, P., Meyer, M., Lewis, C., Bernau, K., Gowing, G., Zimprich, C., Aebischer, P., Svendsen, C. N. and Suzuki, M. (2013). Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model. Mol. Ther. 21, 1602-1610.
25. Mohajeri, M. H., Figlewicz, D. A. and Bohn, M. C. (1999). Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis. Hum. Gene Ther. 10, 1853-1866.
26. Moreno-Igoa, M., Calvo, A. C., Ciriza, J., Muñoz, M. J., Zaragoza, P. and Osta, R. (2012). Non-viral gene delivery of the GDNF, either alone or fused to the Cfragment of tetanus toxin protein, prolongs survival in a mouse ALS model. Restor. Neurol. Neurosci. 30, 69-80.
27. Nagano, M. and Suzuki, H. (2003). Quantitative analyses of expression of GDNF and neurotrophins during postnatal development in rat skeletal muscles. Neurosci. Res. 45, 391-399.
28. Nelson, P. G., Fields, R. D., Yu, C. and Liu, Y. (1993). Synapse elimination from the mouse neuromuscular junction in vitro: a non-Hebbian activity-dependent process. J. Neurobiol. 24, 1517-1530.
29. Nguyen, Q. T., Parsadanian, A. S., Snider, W. D. and Lichtman, J. W. (1998). Hyperinnervation of neuromuscular junctions caused by GDNF overexpression in muscle. Science 279, 1725-1729.
30. Oppenheim, R. W., Houenou, L. J., Johnson, J. E., Lin, L. F., Li, L., Lo, A. C., Newsome, A. L., Prevette, D. M. and Wang, S. (1995). Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 373, 344-346.
31. Paratcha, G. and Ledda, F. (2008). GDNF and GFRalpha: a versatile molecular complex for developing neurons. Trends Neurosci. 31, 384-391.
32. Park, J. W., Vahidi, B., Taylor, A. M., Rhee, S. W. and Jeon, N. L. (2006). Microfluidic culture platform for neuroscience research. Nat. Protoc. 1, 2128-2136.
33. Park, H. S., Liu, S., McDonald, J., Thakor, N. and Yang, I. H. (2013). Neuromuscular junction in a microfluidic device. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2013, 2833-2835.
34. Pasinelli, P., Borchelt, D. R., Houseweart, M. K., Cleveland, D. W. and Brown, R. H., Jr (1998). Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase. Proc. Natl. Acad. Sci. USA 95, 15763-15768.
35. Restani, L., Giribaldi, F., Manich, M., Bercsenyi, K., Menendez, G., Rossetto, O., Caleo, M. and Schiavo, G. (2012). Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons. PLoS Pathog. 8, e1003087.
36. Sanes, J. R. and Lichtman, J. W. (1999). Development of the vertebrate neuromuscular junction. Annu. Rev. Neurosci. 22, 389-442.
37. Sariola, H. and Saarma, M. (2003). Novel functions and signalling pathways for GDNF. J. Cell Sci. 116, 3855-3862.
38. Sathasivam, S., Ince, P. G. and Shaw, P. J. (2001). Apoptosis in amyotrophic lateral sclerosis: a review of the evidence. Neuropathol. Appl. Neurobiol. 27, 257-274.
39. Shi, L., Fu, A. K. Y. and Ip, N. Y. (2012). Molecular mechanisms underlying maturation and maintenance of the vertebrate neuromuscular junction. Trends Neurosci. 35, 441-453.
40. Southam, K. A., King, A. E., Blizzard, C. A., McCormack, G. H. and Dickson, T. C. (2013). Microfluidic primary culture model of the lower motor neuronneuromuscular junction circuit. J. Neurosci. Methods 218, 164-169.
41. Taylor, A. M., Blurton-Jones, M., Rhee, S. W., Cribbs, D. H., Cotman, C. W. and Jeon, N. L. (2005). A microfluidic culture platform for CNS axonal injury, regeneration and transport. Nat. Methods 2, 599-605.
42. Tsui, C. C. and Pierchala, B. A. (2010). The differential axonal degradation of Ret accounts for cell-type-specific function of glial cell line-derived neurotrophic factor as a retrograde survival factor. J. Neurosci. 30, 5149-5158.
43. Wang, C.-Y., Yang, F., He, X.-P., Je, H.-S., Zhou, J.-Z., Eckermann, K., Kawamura, D., Feng, L., Shen, L. and Lu, B. (2002a). Regulation of neuromuscular synapse development by glial cell line-derived neurotrophic factor and neurturin. J. Biol. Chem. 277, 10614-10625.
44. Wang, L.-J., Lu, Y.-Y., Muramatsu, S., Ikeguchi, K., Fujimoto, K., Okada, T., Mizukami, H., Matsushita, T., Hanazono, Y., Kume, A. et al. (2002b). Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis. J. Neurosci. 22, 6920-6928.
45. Wu, H., Xiong, W. C. and Mei, L. (2010). To build a synapse: signaling pathways in neuromuscular junction assembly. Development 137, 1017-1033.
46. Yang, L.-X. and Nelson, P. G. (2004). Glia cell line-derived neurotrophic factor regulates the distribution of acetylcholine receptors in mouse primary skeletal muscle cells. Neuroscience 128, 497-509.
47. Zhang, Y., Moheban, D. B., Conway, B. R., Bhattacharyya, A. and Segal, R. A. (2000). Cell surface Trk receptors mediate NGF-induced survival while internalized receptors regulate NGF-induced differentiation. J. Neurosci. 20, 5671-5678.